logo
Share SHARE
FONT-SIZE Plus   Neg

Forest Labs' Unit To Acquire Royalties For Bystolic From Janssen Pharmaceutica

Forest Laboratories Inc (FRX) Monday revealed that its wholly-owned subsidiary unit, Forest Laboratories Holdings Limited, has entered into a definitive agreement with Janssen Pharmaceutica NV, wherein the subsidiary unit will acquire all U.S. patents and other U.S. and Canadian intellectual property for Bystolic (nebivolol), which is currently approved in the United States for the treatment of hypertension.

FRX revealed that its subsidiary unit has agreed to make a one-time cash payment of $357 million to Janssen Pharmaceutica NV, and, in turn, Janssen Pharmaceutica will assign all U.S. patents and other U.S. and Canadian know-how covering Bystolic, including the nebivolol composition of matter patent in the U.S. to the subsidiary unit of FRX.

The company further revealed that the subsidiary unit will amortize the one-time cash payment over the remaining patent life of Bystolic.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
GoPro Inc. (GPRO) has launched two new mobile video editing applications for its users. The two new mobile apps Quik and Splice will help users to manage, edit, and share all of the content from GoPro cameras and mobile devices. In February, GoPro had acquired two mobile video editing apps, Replay... Fast changing fashion trends have been hitting Aeropostale badly for the last several quarters, and at last it opted for Chapter 11 bankruptcy filing on Wednesday. Google will collaborate with Fiat Chrysler Automobiles N.V. to integrate Google's self-driving technology into the 2017 Chrysler Pacifica Hybrid minivans. The collaboration will expand Google's existing self-driving test program and also marks the first time that Google will be working directly with an automaker to integrate its self-driving system.
comments powered by Disqus
Follow RTT